Edition:
India

Julie Steenhuysen

Biogen scraps two Alzheimer drug trials, wipes $18 billion from market value

22 Mar 2019

CHICAGO/TOKYO Biogen Inc and partner Eisai Co Ltd are ending two late-stage trials of their experimental Alzheimer's disease drug aducanumab, a major setback in the quest to find a treatment for the mind-wasting disease and a blow to Biogen, which lost more than $18 billion of its value on Thursday. | Video

UPDATE 4-Biogen scraps two Alzheimer drug trials, wipes $18 bln from market value

21 Mar 2019

* Analysts question Biogen growth prospects (Recasts first paragraph, adds details; updates shares)

Experts call for halt to gene editing that results in 'designer babies'

13 Mar 2019

CHICAGO Top scientists and ethicists from seven countries on Wednesday called for a global moratorium on gene editing of human eggs, sperm or embryos that would result in genetically-altered babies after a rogue Chinese researcher last year announced the birth of the world's first gene-edited twins.

Experts call for halt to gene editing that results in "designer babies"

13 Mar 2019

CHICAGO, March 13 Top scientists and ethicists from seven countries on Wednesday called for a global moratorium on gene editing of human eggs, sperm or embryos that would result in genetically-altered babies after a rogue Chinese researcher last year announced the birth of the world's first gene-edited twins.

National Cancer Institute chief to serve as acting FDA head

13 Mar 2019

U.S. President Donald Trump's administration has tapped National Cancer Institute Director Norman Sharpless to serve as acting commissioner for the Food and Drug Administration, following the resignation of Scott Gottlieb earlier this month. Sharpless, who has led the National Institutes of Health's cancer unit since 2017, will take over following Gottlieb's exit in April, the U.S. Department of Health and Human Services said on Tuesday.

World's second man cleared of AIDS virus invigorates quest for cure

06 Mar 2019

LONDON/CHICAGO Scientific investigation into the world's second man cleared of the AIDS virus is zooming in on a gene and a treatment side-effect, as newly-enthused researchers strive to find a cure for the disease that has killed millions.

Trump puts on a few pounds, enters obese range: medical report

16 Feb 2019

WASHINGTON/CHICAGO U.S. President Donald Trump has gained weight over the past year and is now in the obese range, although he remains in "very good health overall," according to results of an annual presidential physical examination conducted last week. | Video

UPDATE 2-Trump puts on a few pounds, enters obese range -medical report

15 Feb 2019

WASHINGTON/CHICAGO, Feb 14 U.S. President Donald Trump has gained weight over the past year and is now in the obese range, although he remains in "very good health overall," according to results of an annual presidential physical examination conducted last week.

Gilead misses key goal in NASH liver disease trial, shares sink

12 Feb 2019

CHICAGO Gilead Sciences Inc said on Monday that a late-stage study of a key experimental drug aimed at treating NASH, a progressive fatty liver disease, failed to meet its main goal, sending the company's shares down 4.6 percent in after-hours trading.

J&J becomes first drugmaker to add prices to television ads

08 Feb 2019

CHICAGO Johnson & Johnson said on Thursday it will start adding the price of its medicines to television commercials by next month, becoming the first drugmaker to heed a call by U.S. President Donald Trump for price transparency of drugs advertised directly to consumers on TV.

World News